Goldman Sachs has grown more optimistic about the timing for a coronavirus vaccine saying it expects at least one treatment to be widely available by next year, leading the firm to raise its economic growth outlook for 2021. • Goldman raised its economic forecasts for next year as it expects “at least one vaccine” to be widely distributed by the second quarter of 2021. • While the firm left its economic forecasts for 2020 unchanged—with annualized GDP gains of 25.2% and 8% in the third and fourth quarter, respectively, it upgraded its full-year outlook for 2021. • Goldman is forecasting 2021 GDP growth to hit 6.2% on ... (full story)